SITC 2026 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.

This conference will gather immunologists, oncologists, technologists, and engineers from academia and industry focused on basic research and clinical translation with the goal of fostering interactions among stakeholders that do not normally interact. To achieves this the conference program will feature new approaches targeting innate cells, application of model systems that replicate aspects of human cancer to inform new therapeutic approaches, the application of protein engineering and materials science to bridge gaps in treatment along with the latest innovations regarding T cell state regulation and application of checkpoint therapy in the clinic.

Early Registration Deadline: November 23, 2026
Scholarship Deadline: September 29, 2026
Short Talk Abstract Deadline: September 29, 2026
Poster Abstract Deadline: January 4, 2027

Cochairs

Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York
Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California